Effects of peritoneal dialysis solutions low in GDPs on peritonitis and exit-site infection rates

Jürgen Furkert1, Martin Zeier, Vedat Schwenger

  • 1Nephrology and Gastroenterology, SLK-Kliniken Heilbronn, Bad Friedrichshall, Germany. juergen.furkert@slk-kliniken.de

Abstract

Insights

New biocompatible peritoneal dialysis (PD) solutions, low in glucose degradation products (GDPs), significantly reduce rates of peritonitis and exit-site infections in PD patients. This suggests improved patient outcomes with these advanced PD fluids.

Area of Science:

  • Nephrology
  • Biomaterials Science
  • Clinical Medicine

Background:

  • Peritoneal dialysis (PD) solutions sterilized at low pH contain minimal glucose degradation products (GDPs).
  • GDPs are known to adversely affect the peritoneal membrane.
  • Previous research indicates a link between GDPs and peritoneal membrane complications.

Purpose of the Study:

  • To retrospectively analyze the impact of low-GDP PD solutions on peritonitis and exit-site infection rates.
  • To compare infection incidences between conventional and new PD fluids.
  • To establish a correlation between infection rates and PD treatment duration.

Main Methods:

  • Retrospective analysis of infection data from 120 PD patients.
  • Comparison of infection rates in patients using conventional dialysates (before 2000) versus new, low-GDP fluids (from 2000 onwards).
  • Statistical analysis to determine the significance of observed differences and correlations.

Main Results:

  • Significantly lower rates of peritonitis (p = 0.002) and exit-site infections (p = 0.02) were observed with low-GDP PD solutions.
  • Peritonitis occurred after an average of 48 months with new fluids, compared to earlier occurrences with conventional fluids.
  • Exit-site infections occurred after an average of 34 months with new fluids.

Conclusions:

  • The use of new, biocompatible PD solutions low in GDPs contributes to a significant reduction in peritonitis and exit-site infections.
  • Findings support the hypothesis that reduced GDP exposure improves PD patient outcomes.
  • Further observational studies are recommended to confirm these tendencies, given the unlikelihood of future randomized prospective trials.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...